Bruno A. Sousa
University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bruno A. Sousa.
Journal of the Brazilian Chemical Society | 2015
Sandra S. Ribeiro; Irlon M. Ferreira; João P. F. de Lima; Bruno A. Sousa; Rafaela C. Carmona; Alcindo A. Dos Santos; André L.M. Porto
Enzymatic kinetic resolution (EKR) of (±)-cyanohydrins was performed by using immobilized lipase from Candida antarctica (CALB) under conventional ordinary conditions (orbital shaking) and under microwave radiation (MW). The use of microwave radiation contributed very expressively on the reduction of the reaction time from 24 to 2 h. Most importantly, high selectivity (up to 92% eep) as well as conversion was achieved under MW radiation (50-56%).
Journal of Flow Chemistry | 2016
Leandro H. Andrade; Bruno A. Sousa; Timothy F. Jamison
AbstractThe confinement of a biocatalyst designed to operate under continuous-flow conditions is a strategy developed by nature in order to achieve efficient reactions in biological media. Herein, we present a mimetic model that employs a confined lipase (CAL-B) in the production of several carboxamide derivatives from esters as precursors. The remarkable selectivity of such system is also described when α,β-unsatured carboxylic substrates are employed.
Parasitology International | 2017
Paula Ferreira Brasil; Júlia Araújo de Freitas; Anna Léa Silva Barreto; Camila M. Adade; Leandro Figueira Reis de Sá; Pamella Constantino-Teles; Fabiano T. Toledo; Bruno A. Sousa; Augusto C. Gonçalves; Maria Teresa Villela Romanos; João V. Comasseto; Alcindo A. Dos Santos; Ana Claudia Tessis; Thaïs Souto-Padrón; Rosangela Maria de Araújo Soares; Antonio Ferreira-Pereira
Leishmania (Leishmania) infantum chagasi is one of the agents that cause visceral leishmaniasis. This disease occurs more frequently in third world countries, such as Brazil. The treatment is arduous, and is dependent on just a few drugs like the antimonial derivatives and amphotericin B. Moreover, these drugs are not only expensive, but they can also cause severe side effects and require long-term treatment. Therefore, it is very important to find new compounds that are effective against leishmaniasis. In the present work we evaluated a new group of synthetic amides against the promastigote and amastigote forms of L. infantum chagasi. The results showed that one of these amides in particular, presented very effective activity against the promastigotes and amastigotes of L. infantum chagasi at low concentrations and it also presented low toxicity for mammal cells, which makes this synthetic amide a promising drug for combating leishmaniasis.
Antimicrobial Agents and Chemotherapy | 2017
L. F. Reis de Sá; Fabiano T. Toledo; Augusto C. Gonçalves; Bruno A. Sousa; A. C. A. Dos Santos; P. F. Brasil; V. A. Duarte da Silva; Ana Claudia Tessis; J. L. A. Ramos; Marly Ávila de Carvalho; Erwin Lamping; Antonio Ferreira-Pereira
ABSTRACT Invasive Candida albicans infections are a serious health threat for immunocompromised individuals. Fluconazole is most commonly used to treat these infections, but resistance due to the overexpression of multidrug efflux pumps is of grave concern. This study evaluated the ability of five synthetic organotellurium compounds to reverse the fluconazole resistance of C. albicans clinical isolates. Compounds 1 to 4, at <10 μg/ml, ameliorated the fluconazole resistance of Saccharomyces cerevisiae strains overexpressing the major C. albicans multidrug efflux pumps Cdr1p and Mdr1p, whereas compound 5 only sensitized Mdr1p-overexpressing strains to fluconazole. Compounds 1 to 4 also inhibited efflux of the fluorescent substrate rhodamine 6G and the ATPase activity of Cdr1p, whereas all five of compounds 1 to 5 inhibited Nile red efflux by Mdr1p. Interestingly, all five compounds demonstrated synergy with fluconazole against efflux pump-overexpressing fluconazole-resistant C. albicans clinical isolates, isolate 95-142 overexpressing CDR1 and CDR2, isolate 96-25 overexpressing MDR1 and ERG11, and isolate 12-99 overexpressing CDR1, CDR2, MDR1, and ERG11. Overall, organotellurium compounds 1 and 2 were the most promising fluconazole chemosensitizers of fluconazole-resistant C. albicans isolates. Our data suggest that these novel organotellurium compounds inhibit pump efflux by two very important and distinct families of fungal multidrug efflux pumps: the ATP-binding cassette transporter Cdr1p and the major facilitator superfamily transporter Mdr1p.
Dyes and Pigments | 2014
Javier Fernández-Lodeiro; Marcos F. Pinatto-Botelho; Antônio A. Soares-Paulino; Augusto C. Gonçalves; Bruno A. Sousa; Cleverson Princival; Alcindo A. Dos Santos
Tetrahedron Letters | 2012
Márcio S. Silva; Renan S. Ferrarini; Bruno A. Sousa; Fabiano T. Toledo; João V. Comasseto; Rogério A. Gariani
Tetrahedron | 2012
Bruno A. Sousa; Arthur F. Keppler; Rogério A. Gariani; João V. Comasseto; Alcindo A. Dos Santos
European Journal of Organic Chemistry | 2012
Bruno A. Sousa; Alcindo A. Dos Santos
BMC Microbiology | 2014
Leandro Figueira Reis de Sá; Fabiano T. Toledo; Bruno A. Sousa; Augusto C. Gonçalves; Ana Claudia Tessis; Edison P. Wendler; João V. Comasseto; Alcindo A. Dos Santos; Antonio Ferreira-Pereira
Archive | 2015
Sérgio Luiz Sacurai; Carlos Eduardo Da Costa Touzarim; Fabiano T. Toledo; Bruno A. Sousa